Purpose of review The purpose of the present review is to underline the importance of nanoparticulate carriers, such as polymeric nanoparticles, in the future development of safe and effective formulation in the field of immunotherapy against infectious diseases and cancer. Recent findings Polymeric nanoparticles can modulate the immune response, that is, by targeting antigens to dendritic cells that possess a crucial role in initiating immune responses, and might be potentially useful in immunotherapy. Summary In the last decades, significant progress in research and clinics has been made to offer possible innovative therapeutics for the management of infectious diseases and cancer. Polymeric nanoparticles are particularly adept at facilitating immunotherapeutic approaches because they can be engineered to have different physical properties, encapsulated agents, and surface ligands. Moreover, these systems are administrable for all routes, are capable of being actively taken up by dendritic cells and have shown promising potential in systemic and mucosal immunotherapy. Here, some recent findings on these systems, in their potential applications for infectious and cancer immunotherapy, are reported.

Craparo, E.F., Bondì, M.L. (2012). APPLICATION OF POLYMERIC NANOPARTICLES IN IMMUNOTHERAPY. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 12(6), 658-664.

APPLICATION OF POLYMERIC NANOPARTICLES IN IMMUNOTHERAPY

CRAPARO, Emanuela Fabiola;
2012-01-01

Abstract

Purpose of review The purpose of the present review is to underline the importance of nanoparticulate carriers, such as polymeric nanoparticles, in the future development of safe and effective formulation in the field of immunotherapy against infectious diseases and cancer. Recent findings Polymeric nanoparticles can modulate the immune response, that is, by targeting antigens to dendritic cells that possess a crucial role in initiating immune responses, and might be potentially useful in immunotherapy. Summary In the last decades, significant progress in research and clinics has been made to offer possible innovative therapeutics for the management of infectious diseases and cancer. Polymeric nanoparticles are particularly adept at facilitating immunotherapeutic approaches because they can be engineered to have different physical properties, encapsulated agents, and surface ligands. Moreover, these systems are administrable for all routes, are capable of being actively taken up by dendritic cells and have shown promising potential in systemic and mucosal immunotherapy. Here, some recent findings on these systems, in their potential applications for infectious and cancer immunotherapy, are reported.
2012
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
Craparo, E.F., Bondì, M.L. (2012). APPLICATION OF POLYMERIC NANOPARTICLES IN IMMUNOTHERAPY. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 12(6), 658-664.
File in questo prodotto:
File Dimensione Formato  
CurrOpinAllClinImmunol.pdf

Solo gestori archvio

Descrizione: ARTICOLO PRINCIPALE
Dimensione 221.5 kB
Formato Adobe PDF
221.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/78188
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 20
social impact